A patient receiving total parenteral nutrition (TPN) has developed severe metabolic complications, including elevated liver enzymes, hypokalemia, and signs of possible sepsis. The healthcare team has made adjustments to the TPN and initiated minimal enteral feeding, but the patient's condition has worsened. As the primary nurse, what is the most critical immediate intervention to prioritize for this patient?

B) Administer broad-spectrum antibiotics to address potential sepsis

A) Increase the fluid resuscitation rate to manage hypotension

B) Administer broad-spectrum antibiotics to address potential sepsis

C) Reinforce the need for frequent monitoring of blood glucose levels

D) Consult a dietitian to further adjust the TPN formula

A patient receiving total parenteral nutrition (TPN) has developed new complications including intensified abdominal pain, jaundice, fever, tachycardia, and hypotension despite fluid resuscitation. Which nursing intervention is most critical at this time to address the suspected sepsis or systemic inflammatory response syndrome (SIRS)?

A) Administer broad-spectrum antibiotics as ordered and monitor for effectiveness.

B) Discontinue TPN immediately and switch to full enteral feeding to reduce hepatic strain.

C) Increase fluid resuscitation rates to address hypotension and improve perfusion.

D) Initiate insulin therapy to achieve better glucose control and prevent further complications.

A patient with bloodstream infection due to Klebsiella pneumoniae and suspected acute mesenteric ischemia presents with worsening metabolic acidosis, renal failure, and liver dysfunction. As the primary nurse, what is the most critical initial intervention to prioritize in managing this patient's condition?

A) Administer intravenous fluids to improve tissue perfusion

B) Initiate renal replacement therapy to address acute kidney injury

C) Prepare the patient for possible surgical intervention for bowel ischemia

D) Optimize antibiotic therapy based on sensitivity results

A patient with a confirmed Klebsiella pneumoniae bloodstream infection, early ischemic changes in the small bowel, and deteriorating renal and liver function is being closely monitored in the ICU. As the nurse responsible for this patient, which intervention should be prioritized to stabilize the patient's condition?

D) Implement aggressive fluid resuscitation to improve tissue perfusion and address metabolic acidosis.

A) Increase the frequency of renal function monitoring and prepare for potential dialysis initiation.

B) Administer the broad-spectrum antibiotics meropenem and vancomycin as scheduled to address the bloodstream infection.

C) Consult with the surgical team to assess the need for immediate surgical intervention for bowel ischemia.

D) Implement aggressive fluid resuscitation to improve tissue perfusion and address metabolic acidosis.

A patient with persistent metabolic acidosis and renal impairment is receiving continuous veno-venous hemofiltration (CVVH) and broad-spectrum antibiotics. Despite treatment, the patient shows signs of abdominal guarding and decreased urine output. Which nursing intervention is most critical at this time to prevent further complications?

B) Collaborate with the surgical team for possible exploratory laparotomy.

A) Increase the flow rate of the nasal cannula to improve oxygenation.

B) Collaborate with the surgical team for possible exploratory laparotomy.

C) Adjust the CVVH settings to enhance removal of metabolic wastes.

D) Monitor liver function tests closely to adjust TPN composition.

A 68-year-old patient with septic shock and acute kidney injury is receiving broad-spectrum antibiotics and supportive care. Despite treatment, the patient has persistent metabolic acidosis, diminished urine output, and increasing creatinine levels. Continuous veno-venous hemofiltration (CVVH) has been initiated. As the nurse on the multidisciplinary team, which intervention should you prioritize to prevent further complications while optimizing patient outcomes?

B) Collaborate with the pharmacist to adjust the antibiotic regimen based on renal function changes.

A) Increase the rate of intravenous fluid administration to improve renal perfusion.

B) Collaborate with the pharmacist to adjust the antibiotic regimen based on renal function changes.

C) Monitor for signs of bowel ischemia and prepare for potential surgical intervention.

D) Initiate a higher caloric intake through the TPN to support metabolic demands.

A patient with respiratory acidosis and suspected bowel ischemia is scheduled for an exploratory laparotomy. The patient is currently intubated and on mechanical ventilation, with renal replacement therapy ongoing. What is the nurse's priority intervention to optimize the patient's respiratory status before surgery?

B) Collaborate with the respiratory therapist to adjust ventilator settings to increase ventilation.

A) Increase the FiO2 on the ventilator to improve oxygenation.

B) Collaborate with the respiratory therapist to adjust ventilator settings to increase ventilation.

C) Administer a bronchodilator to decrease airway resistance.

D) Ensure the patient is adequately sedated to reduce metabolic demand.

A patient’s respiratory status is deteriorating with a pH of 7.24, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg despite receiving 6 liters of oxygen via nasal cannula. The patient is also scheduled for an exploratory laparotomy due to suspected bowel ischemia. Which is the most appropriate nursing action to prioritize in managing this patient’s condition?

B) Prepare for immediate intubation and mechanical ventilation.

A) Increase oxygen delivery to 10 liters via non-rebreather mask and reassess.

B) Prepare for immediate intubation and mechanical ventilation.

C) Administer an intravenous diuretic to reduce fluid overload and potential pulmonary edema.

D) Initiate continuous renal replacement therapy to correct metabolic acidosis.

A critically ill patient with acute liver dysfunction and coagulopathy is scheduled for an exploratory laparotomy. The interdisciplinary team has administered fresh frozen plasma and vitamin K to address the coagulopathy. As the nurse responsible for preoperative preparation, what is the priority nursing intervention to ensure patient safety during the procedure?

C) Evaluate the patient's coagulation status by monitoring PT and INR before surgery.

A) Monitor liver enzyme levels hourly to assess liver function recovery.

B) Ensure the administration of additional vitamin K to correct coagulopathy.

C) Evaluate the patient's coagulation status by monitoring PT and INR before surgery.

D) Administer a diuretic to prevent fluid overload during the operation.

A critically ill patient with acute liver dysfunction and coagulopathy is scheduled for an exploratory laparotomy. Given the patient's condition, what is the most important nursing intervention to prioritize before surgery?

B) Monitoring the patient's hemodynamic status continuously to detect any instability

A) Administering the prescribed dose of vitamin K to support hepatic function

B) Monitoring the patient's hemodynamic status continuously to detect any instability

C) Ensuring the administration of fresh frozen plasma to correct coagulopathy

D) Modifying the patient's TPN to reduce protein load and stress on the liver

TPN - Nursing Case Study

Pathophysiology

• Primary mechanism: TPN bypasses the gastrointestinal tract, leading to direct nutrient infusion into the bloodstream, which can result in gut atrophy and impaired mucosal barrier function due to lack of enteral stimulation.

• Secondary mechanism: Prolonged TPN use can cause hepatobiliary dysfunction, including cholestasis and liver steatosis, due to altered bile flow and excessive glucose and lipid administration.

• Key complication: TPN-associated liver disease (TALD) is a severe complication, marked by progressive liver damage and cholestasis, potentially leading to cirrhosis if not managed appropriately.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Type 2 Diabetes Mellitus, Chronic Kidney Disease Stage 4, Coronary Artery Disease with previous myocardial infarction, Peripheral Vascular Disease, and Hypertension

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin, and Insulin Glargine

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and inability to tolerate oral intake

• Key symptoms: Persistent nausea and vomiting, diffuse abdominal tenderness, significant weight loss, and generalized weakness

• Vital signs: Temperature 102.5°F, Heart Rate 130 bpm, Respiratory Rate 28 breaths per minute, Blood Pressure 85/55 mmHg, Oxygen Saturation 89% on room air

Section 1

Following the initial assessment and stabilization efforts, the healthcare team ordered a comprehensive set of diagnostic tests to evaluate the patient's condition further. The lab results revealed severe metabolic derangements: a blood glucose level of 280 mg/dL, serum potassium of 3.0 mEq/L, and elevated liver enzymes with an AST of 110 U/L and ALT of 95 U/L, indicating hepatocellular injury. Additionally, the bilirubin level was markedly elevated at 4.5 mg/dL, suggesting significant cholestasis. His renal function continued to decline, with a creatinine level of 3.8 mg/dL and an estimated glomerular filtration rate (eGFR) of 22 mL/min/1.73 m², consistent with worsening chronic kidney disease. The abdominal ultrasound showed diffuse hepatic steatosis and gallbladder sludge, further supporting the diagnosis of TPN-associated liver disease (TALD).

In light of these findings and the patient's hemodynamic instability, the medical team decided to initiate careful modifications to the TPN formula. They reduced the glucose concentration and adjusted electrolytes to address the hypokalemia. In an attempt to stimulate the gastrointestinal tract and reduce the risk of further hepatic complications, a minimal enteral feeding regimen was introduced cautiously. However, within 48 hours of these interventions, the patient developed new complications: his abdominal pain intensified, and he became increasingly jaundiced. His vital signs demonstrated a persistent fever of 101.8°F, tachycardia at 135 bpm, and hypotension at 82/50 mmHg despite fluid resuscitation, raising concerns for sepsis or systemic inflammatory response syndrome (SIRS).

These developments prompted further diagnostic investigations, including blood cultures and imaging studies, to rule out possible sources of infection or ischemic bowel disease exacerbated by his peripheral vascular disease. The complexity of managing this patient was compounded by the need for precise balancing of his glucose control, renal function preservation, and prevention of further hepatic damage. The healthcare team faced critical decisions on managing his metabolic instability while mitigating the risks of TPN-related complications and potential sepsis, thereby requiring advanced critical thinking and coordinated multidisciplinary care.

Section 2

New Diagnostic Results:

In response to the patient's deteriorating status, the healthcare team expedited additional diagnostic evaluations. Blood cultures returned positive for Klebsiella pneumoniae, confirming a bloodstream infection likely secondary to central line contamination. This finding necessitated immediate initiation of broad-spectrum intravenous antibiotics tailored to the sensitivity profile, including meropenem and vancomycin, given the patient's high risk for multidrug-resistant organisms. Further complicating the clinical picture, the CT scan of the abdomen revealed signs suggestive of early ischemic changes in the small bowel, characterized by bowel wall thickening and pneumatosis intestinalis, raising concerns for acute mesenteric ischemia aggravated by the patient's atherosclerotic disease.

Amidst these developments, laboratory results exhibited worsening metabolic acidosis with a pH of 7.25 and a bicarbonate level of 14 mEq/L, alongside a lactate level climbing to 5 mmol/L, signaling tissue hypoperfusion and anaerobic metabolism. The patient's renal function continued to decline, with a creatinine spike to 4.5 mg/dL and eGFR plummeting to 18 mL/min/1.73 m², necessitating consideration of renal replacement therapy. Concurrently, the liver function tests showed further deterioration, with AST and ALT levels rising to 150 U/L and 120 U/L, respectively, and bilirubin reaching 6.0 mg/dL, indicating progressive liver dysfunction.

These alarming findings prompted an urgent multidisciplinary team meeting to reassess the management plan comprehensively. The primary focus shifted towards stabilizing the patient's hemodynamics, optimizing antibiotic therapy, and evaluating the feasibility of surgical intervention or interventional radiology to address the potential bowel ischemia. The complexity of the case underscored the need for precise coordination of care, balancing aggressive treatment of the infection and ischemic bowel while minimizing additional strain on the liver and kidneys. The team faced critical decisions regarding the timing of interventions and the prioritization of conflicting clinical priorities, emphasizing the importance of advanced clinical judgment in navigating the patient's precarious condition.

Section 3

Response to Interventions:

Following the initiation of broad-spectrum antibiotics and supportive measures, the healthcare team observed subtle yet critical changes in the patient's condition. The patient's vital signs indicated relative hemodynamic stability with a blood pressure of 102/68 mmHg, heart rate of 98 bpm, respiratory rate of 22 breaths per minute, and oxygen saturation of 94% on 4 liters of nasal cannula. However, despite these improvements, the metabolic acidosis persisted with a pH of 7.28 and bicarbonate level remaining low at 16 mEq/L. The lactate level showed a slight decrease to 4.8 mmol/L, suggesting a marginal improvement in tissue perfusion. However, the ongoing renal impairment was concerning as urine output diminished to less than 200 mL over 24 hours, and creatinine levels increased further to 5.0 mg/dL.

The patient's abdominal examination remained concerning, with diffuse tenderness and guarding. The decision was made to initiate renal replacement therapy via continuous veno-venous hemofiltration (CVVH) to address the worsening renal function and acidosis, while carefully managing the patient's fluid status to avoid exacerbating the risk of further ischemic insult to the bowel. Meanwhile, the surgical team remained on standby, ready to intervene should there be a definitive indication of bowel necrosis or perforation, with interventional radiology consulted for the possibility of angiographic assessment or embolization to improve mesenteric blood flow.

As the team continued to closely monitor the patient's response, particular attention was given to the balance between aggressive treatment and the risk of exacerbating liver dysfunction. The multidisciplinary approach was crucial, as the pharmacists adjusted the antibiotic regimen based on renal function, and the nutrition team reevaluated the TPN formula to prevent further hepatic insult. The ongoing challenge was to anticipate potential complications from both the underlying conditions and the interventions themselves, requiring advanced clinical reasoning and prompt, coordinated decision-making to navigate the intricate clinical landscape effectively.

Section 4

As the clinical team continued to monitor the patient, a new complication emerged that required immediate attention and advanced critical thinking. Over the next 12 hours, the patient's respiratory status began to decline, with oxygen saturation dropping to 88% despite increasing supplemental oxygen to 6 liters via nasal cannula. The respiratory rate increased to 28 breaths per minute, and the patient exhibited increased work of breathing with accessory muscle use. A repeat arterial blood gas analysis revealed a further decline in pH to 7.24, persistent hypercapnia with a PaCO2 of 55 mmHg, and a worrisome drop in PaO2 to 60 mmHg. These findings suggested worsening respiratory acidosis superimposed on the existing metabolic acidosis, likely secondary to fluid overload and potential pulmonary edema.

Simultaneously, the patient's abdominal status remained precarious. A repeat CT scan of the abdomen, prompted by the intensifying abdominal pain and the onset of bilious vomiting, showed signs of bowel wall thickening and suspected ischemia in the jejunal region, raising concerns about potential bowel necrosis. The surgical team, after thorough evaluation, decided that exploratory laparotomy was necessary due to the high risk of bowel perforation and sepsis. Interventional radiology's angiographic assessment showed diminished mesenteric blood flow, but embolization was deemed too risky given the patient's current hemodynamic instability.

Faced with these critical developments, the healthcare team had to rapidly adjust their management strategy. The patient was intubated and placed on mechanical ventilation to address the respiratory failure while preparing for surgical intervention. The renal replacement therapy was carefully titrated to manage fluid shifts and electrolyte imbalances, and the TPN formulation was adjusted to minimize hepatic stress before surgery. This phase of the patient's care demanded precise coordination across disciplines to mitigate risks, balance competing priorities, and prepare for the impending surgical procedure, all while maintaining vigilant monitoring to swiftly address any further complications.

Section 5

As the patient was stabilized on mechanical ventilation, the healthcare team focused on the preparation for exploratory laparotomy. However, within a few hours, new diagnostic results introduced another layer of complexity. The patient's latest laboratory tests showed a rapid increase in liver enzymes, with ALT rising to 450 U/L and AST to 390 U/L, indicating acute liver dysfunction. Additionally, the bilirubin level had increased to 4.5 mg/dL, raising concerns about the patient's ability to metabolize the TPN components effectively. Concurrently, coagulation profiles revealed a prolonged prothrombin time (PT) of 22 seconds and an INR of 2.1, suggesting the onset of coagulopathy, likely exacerbated by liver impairment.

The team was faced with the challenge of balancing the need for urgent surgical intervention against the risk of significant bleeding due to the coagulopathy. The situation necessitated a rapid reassessment of the patient's hemodynamic status and a shift in the therapeutic approach. Fresh frozen plasma was administered to address the coagulopathy, and vitamin K was given to support hepatic function. In parallel, the TPN formulation was further modified to reduce protein load and hepatic stress, with additional focus on optimizing the patient's nutritional status pre-operatively.

In light of these developments, the interdisciplinary team convened a critical care conference to reevaluate the patient's surgical candidacy, considering the potential benefits and risks of proceeding with the laparotomy. The discussion emphasized the need for meticulous intraoperative management to minimize blood loss and ensure hemodynamic stability. This phase of care underscored the complexity of managing a critically ill patient with multiple organ dysfunctions, requiring advanced clinical reasoning and precise coordination to navigate the intertwined challenges effectively.